A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT07634484
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT07634484
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Recruiting
Technical summary
Registry record NCT07634484. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2027-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Pemafibrate 0.2 mg/day
- Intervention (Drug)
- Pemafibrate 0.4 mg/day
- Intervention (Drug)
- Placebo
- Lead sponsor
- Kowa Company, Ltd.
Record details
- Record id
cardio:ct-nct07634484- Content hash
02fac772d74e30aa2efd901ba9b3aa11784d845a861358db6d5f7a9c3a43d760